Jane Street’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.4K Buy
16,400
+2,700
+20% +$8.56K ﹤0.01% 11063
2025
Q4
$54.8K Buy
+13,700
New +$76.2K ﹤0.01% 10477
2025
Q2
Sell
-33,500
Closed -$317K 9955
2025
Q1
$317K Sell
33,500
-34,500
-51% -$348K ﹤0.01% 7707
2024
Q4
$765K Sell
68,000
-181,700
-73% -$3.19M ﹤0.01% 5896
2024
Q3
$7.06M Buy
+249,700
New +$6.44M ﹤0.01% 2343
2024
Q2
Sell
-34,300
Closed -$1.12M 9569
2024
Q1
$1.12M Buy
34,300
+18,800
+121% +$600K ﹤0.01% 5202
2023
Q4
$512K Buy
+15,500
New +$439K ﹤0.01% 6719
2023
Q2
Sell
-6,800
Closed -$221K 8896
2023
Q1
$221K Sell
6,800
-15,500
-70% -$490K ﹤0.01% 7705
2022
Q4
$626K Sell
22,300
-8,500
-28% -$244K ﹤0.01% 5748
2022
Q3
$1.11M Buy
30,800
+18,100
+143% +$638K ﹤0.01% 5233
2022
Q2
$390K Sell
12,700
-1,800
-12% -$52.5K ﹤0.01% 7172
2022
Q1
$468K Sell
14,500
-24,700
-63% -$647K ﹤0.01% 7617
2021
Q4
$1.08M Sell
39,200
-92,000
-70% -$2.64M ﹤0.01% 5730
2021
Q3
$4.07M Buy
131,200
+113,700
+650% +$2.73M ﹤0.01% 3077
2021
Q2
$370K Sell
17,500
-6,700
-28% -$134K ﹤0.01% 7801
2021
Q1
$489K Buy
24,200
+8,800
+57% +$167K ﹤0.01% 6844
2020
Q4
$247K Buy
+15,400
New +$204K ﹤0.01% 6679

Other funds holding EVH

Jane Street's EVH Position: Q1 2026 in Review

Jane Street reduced its Evolent Health (EVH) stake by 39% in Q1 2026, selling an estimated $3.69M and leaving 1,790,147 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3815.

Jane Street first reported a position in EVH in Q1 2017 and has held it in 28 quarters since. The position peaked at $12.2M in Q3 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Jane Street held 1,790,147 shares of Evolent Health worth $4.08M as of Q1 2026.
  • Jane Street sold 1,162,800 Evolent Health shares in Q1 2026, an estimated $3.69M.
  • Evolent Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3815 holding.
  • Jane Street first reported a position in Evolent Health in Q1 2017 and has held it in 28 quarters since.
  • Jane Street's Evolent Health position peaked at $12.2M in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.